Evaluation of [<sup>89</sup>Zr]Zr-DFO-2Rs15d Nanobody for Imaging of HER2-Positive Breast Cancer
2023 · Molecular Pharmaceutics · 25 citations
https://doi.org/10.1021/acs.molpharmaceut.3c00360
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
12
Papers
102
Citations
5
h-index
4
i10-index
Maxwell Ducharme is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Radiopharmaceutical Chemistry and Applications & Monoclonal and Polyclonal Antibodies Research & Peptidase Inhibition and Analysis. The author has an h-index of 5, co-authored 11 publications.
ORCID: 0000-0001-9765-2029https://doi.org/10.1021/acs.molpharmaceut.3c00360
https://doi.org/10.1016/j.cpet.2023.04.009
Click to start Chat